Stock Earnings

Question 1

Y-mAbs Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Y-mAbs Therapeutics Incの総資産は$119で、純lossは$-29です。

Question 2

YMABの主要な財務比率は何ですか？

Accepted Answer

Y-mAbs Therapeutics Incの流動比率は4.4、純利益率は-33.33、1株当たり売上高は$1.96です。

Question 3

Y-mAbs Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Y-mAbs Therapeutics Inc largest revenue segment is Novel Antibody-based Therapeutic Products, at a revenue of 85,185,000 in the most earnings release.For geography, United States is the primary market for Y-mAbs Therapeutics Inc, at a revenue of 65,980,999.

Question 4

Y-mAbs Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Y-mAbs Therapeutics Incの純lossは$-29です。

Question 5

Y-mAbs Therapeutics Incに負債はありますか？

Accepted Answer

yes、Y-mAbs Therapeutics Incの負債は27です。

Question 6

Y-mAbs Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Y-mAbs Therapeutics Incの総発行済株式数は44.98株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	85	87	84	65	34	20
Revenue Growth (YoY)	-1%	4%	28.99%	91%	70%	--
Cost of Revenue	15	15	11	7	2	--
Gross Profit	69	72	73	57	32	--
Selling, General & Admin	49	54	43	60	54	44
Research & Development	44	48	50	91	93	93
Operating Expenses	96	102	94	152	148	140
Other Non Operating Income (Expenses)	4	0	3	0	-3	1
Pretax Income	-22	-29	-20	-95	-55	-119
Income Tax Expense	0	0	0	--	--	--
Net Income	-22	-29	-21	-95	-55	-119
Net Income Growth	-8%	38%	-78%	73%	-54%	47%
Shares Outstanding (Diluted)	45.31	44.32	43.64	43.7	43.18	40.12
Shares Change (YoY)	3%	2%	0%	1%	8%	14%
EPS (Diluted)	-0.49	-0.66	-0.49	-2.19	-1.28	-2.97
EPS Growth	-12%	36%	-78%	71%	-56.99%	28.99%
Free Cash Flow	-17	-15	-27	-75	-103	-91
Free Cash Flow Per Share	-0.37	-0.33	-0.61	-1.71	-2.38	-2.26
Gross Margin	81.17%	82.75%	86.9%	87.69%	94.11%	--
Operating Margin	-30.58%	-33.33%	-25%	-144.61%	-338.23%	-595%
Profit Margin	-25.88%	-33.33%	-25%	-146.15%	-161.76%	-595%
Free Cash Flow Margin	-20%	-17.24%	-32.14%	-115.38%	-302.94%	-455%
EBITDA	-26	-29	-21	-94	-115	-119
EBITDA Margin	-30.58%	-33.33%	-25%	-144.61%	-338.23%	-595%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-26	-29	-21	-94	-115	-119
EBIT Margin	-30.58%	-33.33%	-25%	-144.61%	-338.23%	-595%
Effective Tax Rate	0%	0%	0%	--	--	--

Y-mAbs Therapeutics Inc (YMAB) Price

YMAB Stock Price Chart

YMAB Income

Follow-Up Questions